NHLBI Director Calls for Bold Research Ideas to Address Challenging Conditions and Health Inequities
From population health to genetics to molecular studies, University of Miami Miller School of Medicine researchers can help the nation address challenging health conditions and overcome health inequities, according to Gary H. Gibbons, M.D., director of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health.
As irresistibly adorable dogs jumped happily among groups of squealing, laughing medical students sitting on the floor of the student lounge on Monday, second-year student Christine Nunez explained why the Wellness Advisory Council is sponsoring the Miller School of Medicine’s third annual Student Wellness Week.
Hurricane Dorian’s catastrophic trek across the northwest Bahamas highlighted one of the cruelest ironies associated with the changing climate: the small-island states that produce negligible greenhouse gas emissions are among the most vulnerable to hurricanes that have grown stronger, wetter, and slower-moving over the decades.
Researchers with the University of Miami Miller School of Medicine, in collaboration with UM’s Rosenstiel School of Marine and Atmospheric Science, have been awarded state funds that support research efforts to improve the understanding of the potential long-term human-health impacts of harmful blue-green algal blooms (HABs). The Florida Department of Health announced the award on December 9.
Cellular and genetic therapies may hold the key to better outcomes for patients suffering from critical limb ischemia, a condition in which a serious obstruction of the arteries reduces blood flow to the feet, legs or hands, according to Omaida C. Velazquez, M.D., the David Kimmelman Endowed Chair in Vascular and Endovascular Surgery at the University of Miami Miller School of Medicine.